Prof. Chibale lauded for setting up H3D, University of Cape Town
MMV celebrates the inclusion of Prof. Kelly Chibale, Director University of Cape Town (UCT) Drug Discovery & Development Centre (H3D), South Africa, in the top 50 World’s Greatest Leaders 2018 as listed by Fortune magazine. This honour is in recognition of his leadership in instituting a cutting-edge drug discovery unit at UCT.
The magazine states: ‘In much of Africa, the infrastructure to support scientific research is sorely lacking. But Chibale is working to change that. The Zambian chemist has built H3D, Africa’s first integrated drug discovery centre, at the University of Cape Town.’
MMV started working with Prof. Chibale and his team in 2008. Supported by partners including the Gates Foundation, Novartis, South Africa’s government and MMV, H3D has emerged as a state-of-the-art facility with a team of 90 researchers. A new antimalarial compound, MMV048 now in clinical trials, was discovered by an MMV-supported international team led by Prof. Chibale. The compound is also the first antimalarial targeting a Plasmodium kinase and the first new antimalarial medicine to enter phase I studies in Africa.
“MMV is proud to count Kelly and his team among our partners and friends,” said Dr Timothy Wells, MMV’s Chief Scientific Officer. “African research to tackle malaria is rising and Kelly and his team are at the heart of these efforts. We look forward to continuing our collaboration as we jointly strive to find new molecules that can help treat and prevent malaria.”
Prof. Chibale and his team received the MMV Project of the Year award in 2012 in recognition of these outstanding successes. MMV, together with Technology Innovation Agency (TIA) and South African Medical Research Council (SAMRC) have been strengthening the MMV-UCT malaria project further with an extremely fruitful collaboration. Prof. Chibale has also served on MMV’s Expert Scientific Advisory Committee.